Dzidza Mutengo weVITVIQ Pasina Inishuwarenzi
BELVIQ (lorcaserin) mishonga inorema kurasikirwa inogamuchirwa neChadya neDrug Administration (FDA). Kana iwe uri wanyanyisa kana uwandisa uye uine hutano hwehutano hwakakosha, hunogona kukubatsira kuti ureruke. Asi zvinokonzerwa neBIVVIQ uye mari ye BELVIQ inofanira kutarisirwa usati wasarudza kana chirongwa chekudya chakakosha iwe.
Nzira dzeBIVVIQ Dzinoshanda sei
BELVIQ uye BELVIQ XR (kusunungurwa kwakasununguka) ndeye FDA-inogamuchirwa kuti ishandiswe kune vanhu vakuru vane BMI yevanopfuura makumi matatu nepamusoro, kana kune vanhu vane rondedzero yemuviri yevanoda kusvika 27 uye vane unenge humwe humwe hutano hwakakosheswa hwakadai seropa rakakwirira kuoma, rudzi rwechipiri chirwere cheshuga, kana kuti cholesterol yakakwirira.
BELVIQ yakagadzirirwa kukubatsira kuti unzwe wakakwana mushure mekunge wadya zvokudya zvishoma. Mishonga inoshandisa serotonin receptors muuropi yako. Iva serotonin receptors inodzora nzara. Apo pavanoratidza kuti muviri wako unonzwa wakakwana, unogona kukwanisa kudya zvishoma uye kuora muviri.
Kunyora mashoko e BELVIQ kunotsanangura kuti vashandisi vanotora imwe 10 milligram piritsi kaviri zuva rimwe chete pamwe chete nepurogiramu yakaderera yezvokudya uye chirongwa chekurovedza muviri. Maererano neDFA, mushonga uyu unofanirwa kuendeswa kune humwe hupenyu hwomurwere kuti uchengetedze uremu hwakanaka . VARVIQ havafaniri kutorwa nevakadzi vane pamuviri kana kunwisa.
Ndezvipi Zvakawandisa Zvandichasara paVIVIV?
Mumakiriniki ekuedzwa, vatsvakurudzi vakaongorora varwere vanokwana 8000 uye vakawandisa. Ivhareji yakawanda yekurema yakakanganiswa pakati pezvidzidzo izvi zvakave 3 kusvika ku3.7% yehuwandu hwehutatu hwehuviri hwavo. Vanenge 47% varwere vasina chirwere cheshuga vakarasikirwa nezvikamu zvishanu kubva muzana zvehutatu hwavo hwose, zvichienzanisa ne 23% yevarwere vakatora placebo.
Saka semuenzaniso, kana iwe ikozvino uchiyera mapaundi 250, zvingava zvine musoro kutarisira kukanganisa pakati pe7,5 uye 12.5 pounds apo uchitora BELVIQ nekudya uye kuita zvekuita. Kunyange zvazvo izvi zvisingaoneki sekurasikirwa kukuru, vamwe varwere vanogona kuwana hutano hwakanaka kuburikidza nokurasikirwa zvishoma zvishoma.
ICentral for Disease Control inotaura kuti kurasikirwa 5 - 10% yehutachire hwako hwose hunoita kuti utano hune hutano hwakadai sekunatsiridza muropa, ropa rekutsvaira ropa, uye shuga yeropa.
Kana iwe usingarasikirwe 5% yehutatu hwemuviri wako mukati memavhiki 12 ekutanga pa BELVIQ, hazvibviri kuti mushonga uchakushandira iwe, uye chiremba wako angakubvisa iwe kubva kumishonga.
VHIVVIQ Migumisiro Yechipfuva uye Njodzi
Maererano neDFA, zvinowanzovhiringidzika zveVIVVIQ zvinosanganisira misoro, chizivo, kuneta, kunyunyuta, muromo wakaoma, uye kuvimbiswa. Muvanhu vane chirwere cheshuga, migumisiro ine shuga yakaderera yeropa (hypoglycemia), musoro wepamusoro, kurwadziwa shure, kuora, uye kuneta. Dare reNational Institutes of Health rinopa huwandu hwemigumisiro yaunofanira kuongorora uye kukurukura nachiremba wako usati watora mishonga. Chirwere chacho hachibvumirwiwo nevarwere vakaona maitiro kune lorcaserin kana kune chimwe chezvikamu zvezvikamu munguva yakapfuura.
Muchikamu chekutanga chekuedzwa, vatsvakurudzi vakanga vaine hanya nezvehupenyu hwemwoyo kune varwere vanotora BELVIQ. Asi FDA yakabva yagumisa kuti mishonga haifaniri kukonzera matambudziko emwoyo yemagetsi ayo akange ari kukonzerwa mune zvidzidzo zvepakutanga. Zvisinei, BELVIQ haina kuongororwa nevarwere vane chirwere chemwoyo chinonzi valvular uye FDA inokurudzira kuti varwere vane kupererwa kwemwoyo kusagadzikana kunyatsongwarira pavanotora mishonga.
Mukuwedzera, maererano neNew England Journal yemishonga kune zvimwe zvinonetsa kuti mishonga inogona kutakura njodzi yezvinetso zvepfungwa kana zvepfungwa, kunyanya kune vanhu vari kushandisa mamwe mishonga. Maererano neDFA, vashandisi ve BELVIQ vanogona kunge vari kusanganisira serotonin syndrome, kunyanya kana inotorwa nemishonga inowedzera maitiro e serotonin kana kuti inobatsira serotonin receptors. Izvi zvinosanganisira mishonga inoshandiswa kurapa kuora mwoyo uye migraine musoro. Lorcaserin inogona kukonzera kukanganisa mukucherechedza kana kuyeuka.
Belviq Mari uye Inishuwarenzi
Kana iwe uchiverenga mari yako yose yeBITVIQ, unofanirwa kuchengeta mupfungwa kuti muyero maererano neDAA mapiritsi maviri pazuva.
Saka varwere vazhinji vanoda mapiritsi 60 pamwedzi. Iwe unofanirwawo kuyeuka kuti kana iwe uchida kuramba uchirasikirwa nekurema kwako unoda kugara pa BELVIQ uye, hongu, ramba uchibhadhara mishonga.
Mutengo we BELVIQ unofananidzwa nekushandiswa kweinishuwarenzi uye piritsi yaunotora (BELVIQ kana BELVIQ XR). Kana iwe uine inshuwarisi yehutano inobhadhara mari yemishonga, ipapo iwe wega webhadharo zuva rega raizotanga madhora 2 pazuva kuti BELVIQ XR uye $ 2.20 pazuva nokuda kwe BELVIQ nemakadhi ekuchengetedza mari anowanika pane yekambani webhusaiti.
Kana iwe usina inshuwarisi yekuvhara mishonga, unogona kutarisira kubhadhara zvakawanda. Ivhareji mari ye BELVIQ pasina rubatsiro iri pedyo ne $ 3.20 pazuva.
ICHIVIVQ Chakakunakira Iwe Here?
Izvi zvinodhaka mishonga hazvikurudzirwi nokuda kwe "kurasikirwa kwemafuro asina maturo." Iko ndiko kuti, mapiritsi ezvokudya haafaniri kushandiswa kune avo vanoda kungotarisa zviri nani mudivi ravo ravanofarira. Zvechokwadi, pane mari inokosha inofanira kuonekwa kana iwe uchida kutora BELVIQ. Mhinduro dzinoverengeka dzakaoma dzeBIVVIQ dzakataura nezverwendo rurefu rwezvingava nemigumisiro uye zvishoma zvishoma zvekuti zvinogona kukubatsira iwe kurasikirwa. Asi kana wakamboedza dzimwe nzira dzekurema kwekutakura kunze kwekubudirira, ungada kuudza BELVIQ nachiremba wako. Iva nechokwadi chekuyera zviyero zvose uye zvikomborero kana uchitaura nemutano wako wehutano kuti aite sarudzo yakanakisisa yekurapa uye yehupenyu kwauri.
Sources:
> Arena Pharmaceuticals . Arena Pharmaceuticals uye Eisai Anozivisa FDA Kubvumirwa kweB BELVIQ® (lorcaserin HCl) yeHurus Weight Management muVanhu Vakuru avo vanodarika kuwanda neComorbidity kana Vose.
Nzvimbo dzeDarease Control. Utano hwakanaka - hausi kudya, ndiyo mararamiro! http://www.cdc.gov/healthyweight/losing_weight/index.html
Eric Colman, MD, Julie Golden, MD, Mary Roberts, MD, Amy Egan, MD, MPH, Joyce Weaver, Pharm.D., Uye Curtis Rosebraugh, MD, MPH. "Kuongorora kweDAA yeMishonga Dviri yeHisiporese Weight Management." New England Journal of Medicine October 25, 2012.
Zvokudya uye Drug Administration. Mishonga Inotarirwa Nguva Yakare Kurema Kurapa. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm312380.htm
Zvokudya uye Drug Administration. FDA inobvumira Belviq kuti inopore vamwe vanhu vakuru kana vanorema kupfuura vamwe. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm309993.htm
Kutsvaga Alpha. Kuongorora Bhena yeBelviq SeDhiyabesity Drug. http://seekingalpha.com/article/1059621-assessing-arenas-belviq-as-a-diabesity-drug